China Medicine (OTCPK:CHME) - Stock Price, News & Analysis

CHME Stock Overview

Produces and distributes prescription and over the counter drugs, traditional Chinese medicine products, herbs and dietary-supplements, medical devices, and medical formulations in China. More details

CHME fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	0/6
Dividends	0/6

Risk Analysis

Latest financial reports are more than a year old

Does not have a meaningful market cap ($5K)

Shares are highly illiquid

China Medicine Corporation Competitors

Lucy Scientific Discovery

OTCPK:LSDI.F

US$8.8k

Item 9 Labs

OTCPK:INLB

US$701.0

Hero Technologies

OTCPK:HENC

US$563.0

CBD Life Sciences

OTCPK:CBDL

US$1.4m

Price History & Performance

Summary of all time highs, changes and price drops for China Medicine
Historical stock prices
Current Share Price	US$0.0002
52 Week High	US$0.0002
52 Week Low	US$0.0001
Beta	0
11 Month Change	0%
3 Month Change	n/a
1 Year Change	n/a
33 Year Change	-60.00%
5 Year Change	-99.35%
Change since IPO	-99.99%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

	CHME	US Pharmaceuticals	US Market
7D	0%	2.6%	0.5%
1Y	n/a	13.1%	30.7%

Return vs Industry: Insufficient data to determine how CHME performed against the US Pharmaceuticals industry.

Return vs Market: Insufficient data to determine how CHME performed against the US Market.

Price Volatility

Is CHME's price volatile compared to industry and market?
CHME volatility
CHME Average Weekly Movement	n/a
Pharmaceuticals Industry Average Movement	9.9%
Market Average Movement	6.3%
10% most volatile stocks in US Market	16.3%
10% least volatile stocks in US Market	3.1%

Stable Share Price: CHME's share price has been volatile over the past 3 months compared to the US market.

Volatility Over Time: Insufficient data to determine CHME's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
2005	n/a	Senshan Yang	www.cmc621.com/cmc/index.php

China Medicine Corporation produces and distributes prescription and over the counter drugs, traditional Chinese medicine products, herbs and dietary-supplements, medical devices, and medical formulations in China. The company offers various products for applications, including oncology, high blood pressure, and removal of toxins from food and animal feeds. It provides products that treat stagnation of the heart blood, obstruction of qi in the chest, cardiodynia, headache, and dysmenorrhea; upper respiratory tract infection, acute faucitis, acute tonsillitis, acute gastroenteritis, etc.; acute and chronic hepatitis, deferment hepatitis, cholecystitis, etc.; irregular menstruation, dysmenorrhea, and amenorrhea; anemia and deficiency of vital energy; palpitation, dizziness, and fatigue; and cerebral arteriosclerosis and ischemic stroke.

China Medicine Corporation Fundamentals Summary

How do China Medicine's earnings and revenue compare to its market cap?
CHME fundamental statistics
Market cap	US$4.78k
Earnings (TTM)	-US$113.32k
Revenue (TTM)	US$65.76m

0.0x

P/S Ratio

0.0x

P/E Ratio

Is CHME overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
CHME income statement (TTM)
Revenue	US$65.76m
Cost of Revenue	US$43.75m
Gross Profit	US$22.00m
Other Expenses	US$22.11m
Earnings	-US$113.32k

Last Reported Earnings

Sep 30, 2010

Next Earnings Date

n/a

Earnings per share (EPS)	0
Gross Margin	0.00%
Net Profit Margin	0.00%
Debt/Equity Ratio	0.0%

How did CHME perform over the long term?

See historical performance and comparison